Craneware (LON:CRW) Given “Buy” Rating at Berenberg Bank

Berenberg Bank restated their buy rating on shares of Craneware (LON:CRW) in a research note released on Tuesday morning, Marketbeat reports. The brokerage currently has a GBX 2,600 ($32.89) price objective on the stock.

Craneware Stock Performance

CRW opened at GBX 2,330 ($29.47) on Tuesday. The company has a market cap of £822.96 million, a P/E ratio of 11,095.24 and a beta of 0.14. The company has a quick ratio of 1.00, a current ratio of 0.78 and a debt-to-equity ratio of 19.15. The firm’s 50-day moving average price is GBX 2,292.41 and its 200-day moving average price is GBX 2,139.38. Craneware has a 52-week low of GBX 1,290 ($16.32) and a 52-week high of GBX 2,509.20 ($31.74).

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.